Evidence map›Paper›PMID 24064360›Full record

ArticleEndocrinology2013

Regulation of LH receptor mRNA binding protein by miR-122 in rat ovaries.

Bindu Menon, Jennifer Sinden, Meghan Franzo-Romain, Raman Bhadradri Botta, K M J Menon

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Key events in cancer: Dysregulation of SREBPs.Frontiers in pharmacology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Regulation of adrenal and ovarian steroidogenesis by miR-132.Journal of molecular endocrinology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bindu Menon6428 Medical Sciences Building I, 1301 Catherine Street, Ann Arbor, MI 48109-0617. kmjmenon@umich.edu.
Jennifer Sinden
Meghan Franzo-Romain
Raman Bhadradri Botta
K M J Menon
University of Michigan–Ann Arbor · US

Funding

REGULATION OF OVARIAN FUNCTION BY GONADOTROPINSR01HD006656 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MENON, JAIRAM K.M. · 1985 to 2017
$2.1M
NICHD NIH HHS R01 HD006656NICHD NIH HHS R01 HD06656
6 · The paper itself

Abstract

LH receptor (LHR) expression in the ovary is regulated by the RNA binding protein, (LHR mRNA binding protein [LRBP]), which has been identified as being mevalonate kinase. This study examined the role of microRNA miR-122 in LRBP-mediated LHR mRNA expression. Real-time PCR analysis of ovaries from pregnant mare serum gonadotropin/human chorionic gonadotropin (hCG)-primed female rats treated with hCG to down-regulate LHR expression showed that an increase in miR-122 expression preceded LHR mRNA down-regulation. The expression of miR-122 and its regulation was confirmed using fluorescent in situ hybridization of the frozen ovary sections using 5'-fluorescein isothiocyanate-labeled miR-122 locked nucleic acid probe. The increased expression of miR-122 preceded increased expression of LRBP mRNA and protein, and these increases were followed by LHR mRNA down-regulation. Inhibition of protein kinase A (PKA) and ERK1/2 signaling pathways by H89 and UO126, respectively, attenuated the hCG-mediated up-regulation of miR-122 levels. This was also confirmed in vitro using human granulosa cells. These results suggest the possibility that hCG-mediated miR-122 expression is mediated by the activation of cAMP/PKA/ERK signaling pathways. Inhibition of miR-122 by injection of the locked nucleic acid-conjugated antagomir of miR-122 abrogated the hCG-mediated increases in LRBP protein expression. Because it has been previously shown that miR-122 regulates sterol regulatory element-binding proteins (SREBPs) and SREBPs, in turn, regulate LRBP expression, the role of SREBPs in miR-122-mediated increase in LRBP expression was then examined. The levels of active forms of both SREBP-1a and SREBP-2 were increased in response to hCG treatment, and the stimulatory effect was sustained up to 4 hours. Taken together, our results suggest that hCG-induced down-regulation of LHR mRNA expression is mediated by activation of cAMP/PKA/ERK pathways to increase miR-122 expression, which then increases LRBP expression through the activation of SREBPs.

Indexed as

AnimalsCells, CulturedChorionic GonadotropinCyclic AMPCyclic AMP-Dependent Protein KinasesDown-RegulationExtracellular Signal-Regulated MAP KinasesFemaleGene Expression Regulation, EnzymologicHumansLuteinizing HormoneMAP Kinase Signaling SystemMicroRNAsOvaryPhosphotransferases (Alcohol Group Acceptor)RatsChorionic GonadotropinCyclic AMPCyclic AMP-Dependent Protein KinasesExtracellular Signal-Regulated MAP KinasesLuteinizing Hormonemevalonate kinaseMicroRNAsMIRN122 microRNA, ratPhosphotransferases (Alcohol Group Acceptor)Sterol Regulatory Element Binding Proteins

Identifiers

PMID24064360
PMCPMC3836072
OpenAlexW2015978359

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.